Stockreport

Revolution Medicines: Take The Win And Sell Following Large Move Sparked By Buyout Rumors [Seeking Alpha]

Revolution Medicines, Inc.  (RVMD) 
PDF Merck's rumored interest in a deal rekindled interest in shares. RVMD's pipeline centers on Daraxonrasib (RMC-6236), with three advanced programs targeting pancreatic [Read more]